These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 3093175

  • 41. Schistosoma japonicum: treatment of different developmental stages in mice with long-acting praziquantel implants.
    Cheng L, Lei L, Guo S, Zhu C, Rong H, Guo D, Zhang L, Jiang Y, Lin J.
    Exp Parasitol; 2011 Nov; 129(3):254-9. PubMed ID: 21856298
    [Abstract] [Full Text] [Related]

  • 42. [Studies on human cytokine responses before and after praziquantel chemotherapy in an endemic area of schistosomiasis japonica].
    Shen L, Wu HW, Zhang ZS, Weir R, Shao LJ, Xie ZW, Hu LS, Chen SZ, Su C, Zhang T, Taylor MG, Wu GL.
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2000 Nov; 18(1):14-7. PubMed ID: 12567463
    [Abstract] [Full Text] [Related]

  • 43. In vitro and in vivo effect of levopraziquantel, dextropraziquantel versus racemic praziquantel on different developmental stages of Schistosoma japonicum.
    Xiao S, You J, Mei J, Hu Y, Zhou D, Catto BA.
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1998 Nov; 16(5):335-41. PubMed ID: 12078269
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Schistosoma japonicum reinfection after praziquantel treatment causes anemia associated with inflammation.
    Leenstra T, Coutinho HM, Acosta LP, Langdon GC, Su L, Olveda RM, McGarvey ST, Kurtis JD, Friedman JF.
    Infect Immun; 2006 Nov; 74(11):6398-407. PubMed ID: 16923790
    [Abstract] [Full Text] [Related]

  • 48. [Schistosomiasis japonica of the liver].
    Kawashima T, Sekiya C.
    Ryoikibetsu Shokogun Shirizu; 1995 Nov; (7):97-9. PubMed ID: 8749426
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Recovery from immunesuppression in mice infected with Schistosoma japonicum by treatment of praziquantel.
    Kumada M, Hosaka Y, Kawabata M, Asahi H, Kato K, Kobayakawa T, Hayashi S.
    Jpn J Med Sci Biol; 1987 Apr; 40(2):89-93. PubMed ID: 3123753
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. ACTs for schistosomiasis: do they act?
    Utzinger J, Tanner M, Keiser J.
    Lancet Infect Dis; 2010 Sep; 10(9):579-81. PubMed ID: 20705514
    [No Abstract] [Full Text] [Related]

  • 60. Mast-cell-dependent histamine release after praziquantel treatment of Schistosoma japonicum infection: implications for chemotherapy-related adverse effects.
    Matsumoto J, Matsuda H.
    Parasitol Res; 2002 Oct; 88(10):888-93. PubMed ID: 12209328
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.